|
Bosutinib Clinical Trials
3 actively recruiting trials across 2 locations
Pipeline
Phase 2: 1Phase 3: 1Phase 4: 1
Top Sponsors
- Novartis Pharmaceuticals1
- Canadian Cancer Trials Group1
- Ascentage Pharma Group Inc.1
Indications
- Cancer3
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive1
- CML, Chronic Phase1
- Chronic Myelogenous Leukemia1
- CML1
Other1 trial
Ann Arbor, Michigan1 trial
Asciminib Roll-over Study
Michigan Med University of Michigan
Phase 4
Houston, Texas1 trial
Study of Olverembatinib (HQP1351) in Patients With CP-CML
MD Anderson Cancer Center
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.